|
Volumn 38, Issue 4, 2001, Pages S161-S164
|
Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy
a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e
d
Inoue Hospital
(Japan)
|
Author keywords
Advanced glycation end products (AGEs); Intracellular calcium; Osteocalcin; Parathyroid hormone (PTH); Type I collagen
|
Indexed keywords
ADVANCED GLYCATION END PRODUCT;
BOVINE SERUM ALBUMIN;
CALCITRIOL;
CALCIUM ION;
COLLAGEN TYPE 1;
COMPLEMENTARY DNA;
OSTEOCALCIN;
PARATHYROID HORMONE;
RNA;
BONE DISEASE;
CALCIUM CELL LEVEL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
HUMAN;
HUMAN CELL;
OSTEOBLAST;
PARATHYROID CELL;
PROMOTER REGION;
RENAL OSTEODYSTROPHY;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SECONDARY HYPERPARATHYROIDISM;
CALCITRIOL;
CALCIUM;
CELLS, CULTURED;
COLLAGEN TYPE I;
DIABETIC NEPHROPATHIES;
GLYCOSYLATION END PRODUCTS, ADVANCED;
HUMANS;
KIDNEY FAILURE, CHRONIC;
OSTEOBLASTS;
OSTEOCALCIN;
PARATHYROID GLANDS;
PARATHYROID HORMONE;
PEPTIDE FRAGMENTS;
PROCOLLAGEN;
RENAL OSTEODYSTROPHY;
|
EID: 0034805769
PISSN: 02726386
EISSN: None
Source Type: Journal
DOI: 10.1053/ajkd.2001.27428 Document Type: Article |
Times cited : (82)
|
References (11)
|